Cost effectiveness of low-molecular weight heparin versus warfarin following hip replacement surgery.

@article{Saunders1998CostEO,
  title={Cost effectiveness of low-molecular weight heparin versus warfarin following hip replacement surgery.},
  author={Michael E Saunders and Richard E Grant},
  journal={Journal of the National Medical Association},
  year={1998},
  volume={90 11},
  pages={677-80}
}
Little information is available on the efficacy of low-molecular-weight heparin (enoxaparin) versus warfarin for treatment of deep vein thrombosis and pulmonary embolism following hip replacement surgery. Still less is known of the comparative cost effectiveness of these two therapies. A retrospective study was done on 56 patients who underwent elective hip surgery at an urban medical center between 1991 and 1996. All patients received enoxaparin or warfarin for purposes of thromboprophylaxis… CONTINUE READING